HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 191 filers reported holding HAEMONETICS CORP in Q1 2014. The put-call ratio across all filers is 3.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $2,000 | -90.0% | 40 | -92.7% | 0.00% | -100.0% |
Q4 2014 | $20,000 | +5.3% | 545 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $19,000 | 0.0% | 545 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $19,000 | +5.6% | 545 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $18,000 | -98.8% | 545 | -98.6% | 0.00% | -96.8% |
Q2 2013 | $1,557,000 | +21.4% | 37,664 | +19.9% | 0.03% | +24.0% |
Q1 2013 | $1,283,000 | -21.7% | 31,424 | -21.7% | 0.02% | -26.5% |
Q4 2012 | $1,639,000 | +15.1% | 40,127 | +126.0% | 0.03% | +3.0% |
Q3 2012 | $1,424,000 | +118.1% | 17,755 | +101.6% | 0.03% | +94.1% |
Q2 2012 | $653,000 | +17.2% | 8,805 | +10.2% | 0.02% | +21.4% |
Q1 2012 | $557,000 | +19.8% | 7,990 | +5.2% | 0.01% | +16.7% |
Q4 2011 | $465,000 | +22.4% | 7,595 | +16.8% | 0.01% | +9.1% |
Q3 2011 | $380,000 | -4.5% | 6,505 | +5.1% | 0.01% | +10.0% |
Q2 2011 | $398,000 | +23.2% | 6,190 | +25.7% | 0.01% | +25.0% |
Q1 2011 | $323,000 | +80.4% | 4,925 | +74.0% | 0.01% | +60.0% |
Q4 2010 | $179,000 | – | 2,830 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
Dean Capital Management | 15,309 | $812,000 | 0.70% |
Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |